DexCom
DXCM
#788
Rank
ยฃ22.60 B
Marketcap
ยฃ60.61
Share price
-1.08%
Change (1 day)
32.78%
Change (1 year)

P/S ratio for DexCom (DXCM)

P/S ratio as of November 2026 (TTM): 5.88

According to DexCom's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.8. At the end of 2026 the company had a P/S ratio of 6.31.

P/S ratio history for DexCom from 2007 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20266.3112.75%
20255.60-27.98%
20247.77133.38%
20233.33-78.2%
202215.3-28.13%
202121.315.35%
202018.435.74%
201913.629.88%
201810.550.57%
20176.94-21.14%
20168.80-47.12%
201516.61.39%
201416.42.32%
201316.069.65%
20129.4614.76%
20118.24-52.7%
201017.439.24%
200912.549.55%
20088.37-84.68%
200754.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.59 12.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.83-34.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
3.44-41.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
2.80-52.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
9.17 56.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
1.18-79.85%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
0.2217-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
8.06 37.10%๐Ÿ‡บ๐Ÿ‡ธ USA